Sonnet BioTherapeutics Holdings, Inc. (the “Company” or “Sonnet”) (NASDAQ: SONN), a clinical-stage company developing targeted immunotherapeutic drugs, today announced its abstract has been accepted ...

Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK ...

on time Quality of oral presentation: Clear and concise project overview and able to answer questions adequately Quality of poster: Appropriate, understandable, and informative overview of your ...

Since the Arkansas Integrative Metabolic Research Center was established in 2021, supported researchers have secured over $34 million in external research funding and a majority of NIH funding on ...

Flatiron Health today announced its planned presence at the American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO GU), including three accepted abstracts for poster presentation.

The class and poster session gave her hope ... Marion Suiseeya said watching the research presentation was “bittersweet” because it was her last group of students at Northwestern.

GC Biopharma, a South Korean biopharmaceutical company, announced on Feb. 10th that it presented development updates on its ...

Data from DELIVER and ACHIEVE Clinicals Trial to be Presented -- Presentation on ACHIEVE Trial in DM1 and Company Symposium to Feature Data on ...

Mason Hipp isn’t content to go through the motions during his college years. The sophomore chemistry major chose Kennesaw ...

Poster Details Poster Presentation Title: Efficacy and Safety Results of Adult ... 1 study of its novel internally discovered FGFR2 inhibitor. In addition, the Cogent Research Team is developing a ...